glp 1 epilepsy GLP-1 receptor agonists in people with epilepsy: A scoping review of clinical data, safety, and therapeutic implications GLP-1 diabetes drugs linked to
Description
Severe diabetic retinopathy with macular edema may worsen with rapid glucose lowering in type 2 diabetes
Santiago-Rodriguez, T
This was observed for patients with and without diabetes
The milligram numbers reflect different molecular weights and different receptor binding profiles
These agents include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist
Its foundational
